Skip to main content
Log in

CYP/PON genetic variations as determinant of organophosphate pesticides toxicity

  • REVIEW ARTICLE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

In the present scenario of increased accumulation of pesticides in the environment, it is important to understand its impact on human health. The focus is on gene–environment interaction, highlighting the consequences and factors that may halt the biotransformation of some pesticides and change their actual dose response curve due to mixed exposure to pesticides. The paraoxonase and cytochrome P450 gene families are involved in the metabolism of oxon derivate (toxic than its parent compound) of organophosphate pesticides, thus, mutations in these genes may impact the metabolic outcome of pesticides and subsequent health hazards. The complex multi gene–environment interaction and one gene – one risk factor are two different aspects to understand the potential health effect related to environmental exposure studies. The genetic polymorphisms are associated with varying levels of risk within the population, as gene products of varied genotype alter the biotransformation of exogenous/endogenous substrates. This paper is aimed to review the impact of endogenous and exogenous factors on a mechanistic pathway of organophosphate pesticide biotransformation and various risk associated with it among the human population. Understanding the genetic polymorphism of genes involved in pesticide metabolism and highlighting the gene isoform dependent interindividual differences to metabolize particular pesticides may help us to unravel the reasons behind differential toxicity for pesticides exposure than expected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Abass K., Reponen P., Jalonen J. and Pelkonen O. 2007 In vitro metabolism and interaction of profenofos by human, mouse and rat liver preparations. Pest. Biochem. Physiol. 87, 238–247.

    Article  CAS  Google Scholar 

  • Abass K., Reponen P., Mattila S., Rautio A. and Pelkonen O. 2014 Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic models. Toxicol. Lett. 224, 300–309.

    Article  CAS  PubMed  Google Scholar 

  • Abass K., Turpeinen M., Rautio A., Hakkola J. and Pelkonen O. 2012 Metabolism of pesticides by human cytochrome p450 enzymes in vitro—a survey. In Insecticides—advances in integrated pest management, pp. 165–194. InTech Open Access Publisher, New York, USA.

  • Agachan B., Yilmaz H., Karaali Z. and İsbir T. 2004 Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem. Funct. 22, 163–168.

    Article  CAS  PubMed  Google Scholar 

  • Aksoy-Sagirli P., Cakmakoglu B., Isbir T., Kaytan-Saglam E., Kizir A., Topuz E. et al. 2011 Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res. 31, 2225–2229.

    CAS  PubMed  Google Scholar 

  • Al-Hakeem M. M., Abotalib Z., Alharbi K. K. and Khan I. A. 2014 Relationship between the paraoxonase 1 gene glutamine 192 to arginine polymorphism and gestational diabetes mellitus in Saudi women. Clin. Biochem. 47, 122–125.

    Article  CAS  PubMed  Google Scholar 

  • Andersen H. R., Wohlfahrt-Veje C., Dalgård C., Christiansen L., Main K. M., Nellemann C. et al. 2012 Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school age. PLoS One 7, e368hHH30.

    Article  CAS  Google Scholar 

  • Anuradha A., Lakshmi-Kalpana V., Kirmani N. and Rao P. J. 2016 CYP polymorphism and its association with tobacco usage and susceptibility to head and neck cancer. In Next generation DNA led technologies (ed. S. Avadhanam, G. Jyothsna and A. Kashyap), pp. 35–48. Springer, Singapore.

    Google Scholar 

  • Atasoy H., Güleç-Yilmaz S., Ergen A., Görmüş U., Küçükhüseyin Ö., Dalan B. et al. 2015 Paraoxonase1 192 (PON1 192) gene polymorphism and serum paraoxonase activity in panic disorder patients. In Vivo 29, 51–54.

    CAS  PubMed  Google Scholar 

  • Attar R., Atasoy H., Inal-gültekin G. Ü. L. D. A. L., Timirci-Kahraman Ö. Z. L. E. M., Güleç-Yilmaz S. E. D. A., Dalan A. B. et al. 2015 The effects of PON1 gene Q192R variant on the development of uterine leiomyoma in Turkish patients. In Vivo 29, 243–246.

    CAS  PubMed  Google Scholar 

  • Atterberry T. T., Burnett W. T. and Chambers J. E. 1997 Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol. Appl. Pharmacol. 147, 411–418.

    Article  CAS  PubMed  Google Scholar 

  • Bahrehmand F., Vaisi-Raygani A., Ahmadi R., Kiani A., Rahimi Z., Tavilani H. and Pourmotabbed T. 2013 Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus. Iran J. Allergy Asthma Immunol. 12, 211–219.

    CAS  PubMed  Google Scholar 

  • Baker J. R., Satarug S., Reilly P. E. B., Edwards R. J., Ariyoshi N., Kamataki N. et al. 2001 Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples. Biochem. Pharmacol. 62, 713–721.

    Article  CAS  PubMed  Google Scholar 

  • Baker J. R., Satarug S., Urbenjapol S., Edwards R. J., Williams D. J. et al. 2002 Associations between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoprotein. Biochem. Pharmacol. 63, 693–696.

    Article  CAS  PubMed  Google Scholar 

  • Bakke M. and Lund J. 1995 Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 3,5-monophosphate responsive sequence in the bovine CYP17 gene. Mol. Endocrinol. 9, 327–339.

    CAS  PubMed  Google Scholar 

  • Bednarska-Makaruk M. E., Krzywkowski T., Graban A., Lipczyńska-Łojkowska W., Bochyńska A., Rodo M. et al. 2013 Paraoxonase 1 (PON1) gene –108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia Folia. Neuropathology 51, 111–119.

    CAS  Google Scholar 

  • Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C. et al. 2000 Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 28, 1335–1342.

    CAS  PubMed  Google Scholar 

  • Blanco-Munoz J., Aguilar-Garduño C., Gamboa-Avila R., Rodríguez-Barranco M., Perez-Mendez O., Huesca-Gomez C. et al. 2013 Association between PON1 genetic polymorphisms and miscarriage in mexican women exposed to pesticides . Sci. Total Environ. 449, 302–308.

    Article  CAS  PubMed  Google Scholar 

  • Blatter M. C., James R. W., Messmer S., Barja F. and Pometta D. 1993 Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, k-45 . Eur. J. Biochem. 211, 871–879.

    Article  CAS  PubMed  Google Scholar 

  • Bonner M. R., Williams B. A., Rusiecki J. A., Blair A., Freeman L. E. B., Hoppin J. A. et al. 2010 Occupational exposure to terbufos and the incidence of cancer in the agricultural health study. Cancer Causes Control 21, 871–877.

    Article  PubMed  PubMed Central  Google Scholar 

  • Boshtam M., Emami Razavi A., Pourfarzam M., Ani M., Naderi G. A., Basati G. et al. 2013 Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein. Dis. Markers 35, 273–280.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bounafaa A., Berrougui H., Ikhlef S., Essamadi A., Nasser B., Bennis A. et al. 2014 Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients. Clin. Biochem. 47, 318–325.

    Article  CAS  PubMed  Google Scholar 

  • Brophy V. H., Jampsa R. L., Clendenning J. B., McKinstry L. A., Jarvik G. P. and Furlong C. E. 2001 Effects of 5 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet. 68, 1428–1436.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buratti F. M., D’aniello A., Volpe M. T., Meneguz A. and Testai E. 2005 Malathion bioactivation in the human liver: the contribution of different cytochrome P450 isoforms. Drug Metab. Dispos. 33, 295–302.

    Article  CAS  PubMed  Google Scholar 

  • Buratti F. M., Volpe M. T., Fabrizi L., Meneguz A., Vittozzi L. and Testai E. 2002 Kinetic parameters of opt pesticide desulphuration by c-DNA expressed human CYPS. Environ. Toxicol. Pharmacol. 11, 181–190.

    Article  CAS  PubMed  Google Scholar 

  • Buratti F. M., Volpe M. T., Meneguz A., Vittozzi L. and Testai E. 2003 CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol. 186, 143–154.

    Article  CAS  PubMed  Google Scholar 

  • Butler A. M. and Murray M. 1997 Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. J. Pharmacol. Exp. Ther. 280, 966–973.

    CAS  PubMed  Google Scholar 

  • Campo S., Sardo A. M., Campo G. M., Avenoso A., Castaldo M., D’Ascola A. et al. 2004 Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy. Mutat. Res. Fund Mol. Mech. Mut. 546, 75–80.

    Article  CAS  Google Scholar 

  • Carlone D. L. and Richards J. S. 1997 Functional interactions, phosphorylation, and levels of 3 ,5-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol. Endocrinol. 11, 292–304.

    CAS  PubMed  Google Scholar 

  • Casida J. E. 2010 Curious about pesticide action. J. Agricult. Food Chem. 59, 2762–2769.

    Article  CAS  Google Scholar 

  • Chen S., Wang K. and Wan Y. J. 2010 Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. Biochem. Pharmacol. 79, 270–276.

    Article  CAS  PubMed  Google Scholar 

  • Choi J., Hodgson E. and Rose R. L. 2004 Inhibition of trans-permethrin hydrolysis in human liver fractions by chloropyrifosoxon and carbaryl. Drug Metabol. Drug Interact. 20, 233–246.

    Article  CAS  PubMed  Google Scholar 

  • Costa L. G., Cole T. B., Jarvik G. P. and Furlong C. E. 2003 Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54, 371–392.

    Article  CAS  PubMed  Google Scholar 

  • Costa L. G., Vitalone A., Cole T. B. and Furlong C. E. 2005 Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69, 541–550.

    Article  CAS  PubMed  Google Scholar 

  • Crane A. L., Klein K., Zanger U. M. and Olson J. R. 2012 Effect of CYP2B6* 6 and CYP2C19* 2 genotype on chlorpyrifos metabolism. Toxicology 293, 115–122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • D’Agostino J., Zhang H., Kenaan C. and Hollenberg P. F. 2015 Mechanism-based inactivation of human cytochrome P450 2B6 by chlorpyrifos. Chem. Res. Toxicol. 28, 1484–1495.

    Article  PubMed  CAS  Google Scholar 

  • Dadachanji R., Shaikh N., Khavale S., Patil A., Shah N. and Mukherjee S. 2015 PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome. Fertil. Steril. 104, 207–216.

    Article  CAS  PubMed  Google Scholar 

  • Davies H. G., Richter R. J., Keifer M., Broomfield C. A., Sowalla J. and Furlong C. E. 1996 The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, somanandsarin. Nat. Genet. 14, 334–336.

    Article  CAS  PubMed  Google Scholar 

  • Debord J., Dantoine T., Bollinger J. C., Abraham M. H., Verneuil B. and Merle L. 1998 Inhibition of arylesterase by aliphatic alcohols. Chem. Biol. Interact. 113, 105–115.

    Article  CAS  PubMed  Google Scholar 

  • Du L., Neis M. M., Ladd P. A. and Keeney D. S. 2006 Differentiation-specific factors modulate epidermal CYP1–4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther. 319, 1162–1171.

    Article  CAS  PubMed  Google Scholar 

  • Dursun A., Cicek S., Keni F. M., Karakas-Celik S., Sezer T. and Altinyazar C. H. 2014 The relation of PON1-L55M gene polymorphism and clinical manifestation of Behcet’s disease. Acta Biochim. Pol. 61, 271–274.

    PubMed  Google Scholar 

  • Dzul-Caamal R., Domínguez-Lòpez M. L., Olivares-Rubio H. F., García-Latorre E. and Vega-López A. 2014 The relationship between the bioactivation and detoxification of diazinon and chlorpyrifos, and the inhibition of acetylcholinesterase activity in Chirostoma jordani from three lakes with low to high organophosphate pesticides contamination. Ecotoxicology 23, 779–790.

    Article  CAS  PubMed  Google Scholar 

  • Eddleston M., Mohamed F., Davies J. O., Eyer P., Worek F., Sheriff M. R. et al. 2006 Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 99, 513–522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edwards T. M. and Myers J. P. 2008 Environmental exposures and gene regulation in disease etiology. Cien Saude Colet. 13, 269–281.

    Article  PubMed  Google Scholar 

  • El-Banna H. and Jiman-Fatani A. 2014 Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC Musculoskelet. Disord. 15, 379.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Erlich P. M., Lunetta K. L., Cupples L. A., Huyck M., Green R. C., Baldwin C. T. et al. 2006 Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum. Mol. Gen. 15, 77–85.

    Article  CAS  PubMed  Google Scholar 

  • Ernest H. and Andrew D. W. 2012 Human metabolic interactions of pesticides: Inhibition, induction, and activation, parameters for pesticide qsar and pbpk/pd models for human risk assessment. Am. Chem. Soc. 1099, 115–132.

    Google Scholar 

  • Farcas A., Matei A. V., Florian C., Badea M. and Coman G. 2013 Health effects associated with acute and chronic exposure to pesticides. In Environmental security assessment and management of obsolete pesticides in southeast Europe, pp. 103–110. Springer, Dordrecht, The Netherlands.

    Google Scholar 

  • Feingold K. R., Memon R. A., Moser A. H. and Grunfeld C. 1998 Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase responses. Atherosclerosis 139, 307–315.

    Article  CAS  PubMed  Google Scholar 

  • Ferretti G., Bacchetti T., Marotti E. and Curatola G. 2003 Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity. Metabolism 52, 146–151.

    Article  CAS  PubMed  Google Scholar 

  • Fire A., Kostas S., Montgomery M., Timmons L., Xu S., Tabara H. et al. 2013 Genetic inhibition by double-stranded RNA. US Patent No. 20,130,029,425.

  • Flaskos J. 2012 The developmental neurotoxicity of organophosphorus insecticides: a direct role for the oxon metabolites. Toxicol. Lett. 209, 86–93.

    Article  CAS  PubMed  Google Scholar 

  • Foxenberg R. J., McGarrigle B. P., Knaak J. B., Kostyniak P. J. and Olson J. R. 2007 Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos. Drug Metab. Dispos. 35, 189–193.

    Article  CAS  PubMed  Google Scholar 

  • Fuhrman B., Nitzan O., Karry R., Volkova N., Dumler I. and Aviram M. 2007 Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis 195, e108–e116.

    Article  CAS  PubMed  Google Scholar 

  • Fujioka K. and Casida J. E. 2007 Glutathione s-transferase conjugation of organophosphorus pesticides yields s-phospho-, s-aryl-, and s-alkylglutathione derivatives. Chem. Res. Toxicol. 20, 1211–1217.

    Article  PubMed  CAS  Google Scholar 

  • George J., Byth K. and Farrell G. C. 1995 Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol. 50, 727–730.

    Article  CAS  PubMed  Google Scholar 

  • Gómez-Martín A., Hernández A. F., Martínez-González L. J., González-Alzaga B., Rodríguez-Barranco M., López-Flores I. et al. 2015 Polymorphisms of pesticide-metabolizing genes in children living in intensive farming communities. Chemosphere 139, 534–540.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez F. J., Peters J. M. and Cattley R. C. 1998 Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor α. J. Natl. Cancer Inst. 90, 1702–1709.

    Article  CAS  PubMed  Google Scholar 

  • Gonzalvo M. C., Gil F., Hernández A. F., Villanueva E. and Pla A. 1997 Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem. Biol. Interact. 105, 169–179.

    Article  CAS  PubMed  Google Scholar 

  • Guengerich F. P. 1993 Cytochrome p450 enzymes. Am. Sci. 81, 440–447.

    Google Scholar 

  • Hankinson O. 1995 The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307–340.

    Article  CAS  PubMed  Google Scholar 

  • Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonsky O., Meged R. et al. 2004 Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol. 11, 412–419.

    Article  CAS  PubMed  Google Scholar 

  • Hassett C., Richter R. J., Humbert R., Chapline C., Crabb J. W., Omiecinski C. J. et al. 1991 Characterization of DNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 30, 10141–10149.

    Article  CAS  PubMed  Google Scholar 

  • Hazleton L. 1955 Pesticide toxicity, review of current knowledge of toxicity of cholinesterase inhibitor insecticides. J. Agricult. Food Chem. 3, 312–319.

    Article  CAS  Google Scholar 

  • Hedrick C. C., Hassan K., Hough G. P., Yoo J., Simzar S., Quinto C. R. et al. 2000 Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler. Thromb. Vasc. Biol. 20, 1946–1952.

    Article  CAS  PubMed  Google Scholar 

  • Hernández A. F., Gil F., Lacasaña M., Rodríguez-Barranco M., Gómez-Martin A., Lozano D. et al. 2013a Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes. Food Chem. Toxicol. 61, 164–170.

  • Hernández A. F., Parrón T., Tsatsakis A. M., Requena M., Alarcón R. and López-Guarnido O 2013b Toxic effects of pesticide mixtures at a molecular level: their relevance to human health. Toxicology 307, 136–145.

  • Hernández A. F., Gonzalvo M. C., Gil F., Villanueva E. and Pla A. 1997 Divergent effects of classical inducers on rat plasma and microsomial fraction paraoxonase and arylesterase. Environ. Toxicol. Pharmacol. 3, 83–86.

    Article  PubMed  Google Scholar 

  • Hodgson E. 2012 Biotransformation of individual pesticides: some examples. In Pesticide biotransformation and disposition, Chap. 9, 3rd edition, pp. 195–207, Academic Press, Elsevier Oxford, UK.

  • Hodgson E. and Rose R. L. 2005 Human metabolism and metabolic interactions of deployment-related chemicals. Drug Metab. Rev. 37, 1–39.

    Article  CAS  PubMed  Google Scholar 

  • Hodgson E. and Rose R. L. 2007 The importance of cytochrome p450 2b6 in the human metabolism of environmental chemicals. Pharmacol. Ther. 113, 420–428.

    Article  CAS  PubMed  Google Scholar 

  • Hodgson E. and Rose R. L. 2006 Organophosphorus chemicals: potent inhibitors of the human metabolism of steroid hormones and xenobiotics. Drug Metab. Rev. 38, 149–162.

    Article  CAS  PubMed  Google Scholar 

  • Humbert R., Adler D. A., Disteche C. M., Hassett C., Omiecinski C. J. and Furlong C. E. 1993 The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3, 73–76.

    Article  CAS  PubMed  Google Scholar 

  • James R. W., Leviev I. and Righetti A. 2000a Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101, 2252–2257.

  • James R. W., Leviev I., Ruiz J., Passa P., Froguel P. and Garin M. C. 2000b Promoter polymorphism T(–107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49, 1390–1393.

  • Jarvik G. P., Rozek L. S., Brophy V. H., Hatsukami T. S., Richter R. J., Schellenberg G. D. et al. 2000 Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype. Arterioscler. Thromb. Vasc. Biol. 20, 2441–2447.

    Article  CAS  PubMed  Google Scholar 

  • Jarvik G. P., Tsai N. T., McKinstry L. A., Wani R., Brophy V. H., Richter R. J. et al. 2002 Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler. Thromb. Vasc. Biol. 22, 1329–1333.

    Article  CAS  PubMed  Google Scholar 

  • Kale B. 2013 Xanthine oxidase and paraoxonase-1 as new markers in the diagnosis and prognosis of organophosphorus pesticide poisoning. Int. J. Biol. Res. 1, 10–14.

    Google Scholar 

  • Kaliste-Korhonen E., Tuovinen K. and Hanninen O. 1998 Effects of phenobarbital and γ-naphtoflavone on activities of different rat esterases after paraoxon exposure. Gen. Pharmacol. 31, 307–312.

    Article  CAS  PubMed  Google Scholar 

  • Kao Y., Donaghue K. C., Chan A., Bennetts B. H., Knight J. and Silink M. 2002 Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabetic Med. 19, 212–215.

    Article  CAS  PubMed  Google Scholar 

  • Kato S., Shields P. G., Caporaso N. E., Hoover R. N., Trump B. F. et al. 1992 Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 52, 6712–6715.

    CAS  PubMed  Google Scholar 

  • Khateeb J., Kiyan Y., Aviram M., Tkachuk S., Dumler I. and Fuhrman B 2012 Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator–activated receptor- γ. Nuclear Export. Arterioscler. Thromb. Vasc. Biol. 32, 449–458.

    Article  CAS  PubMed  Google Scholar 

  • Kim J. H., Stansbury K. H., Walker N. J., Trush M. A., Strickland P. T. and Sutter T. R. 1998 Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19, 1847–1853.

    Article  CAS  PubMed  Google Scholar 

  • Kirbas A., Kirbas S., Cure M. C. and Tufekci A. 2013 Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic parkinson’s disease. J. Clin. Neurosci. 21, 451–455.

    Article  PubMed  CAS  Google Scholar 

  • Kiss I., Orsós Z., Gombos K., Bogner B., Csejtei A. et al. 2007 Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res. 27, 2931–2937.

    CAS  PubMed  Google Scholar 

  • Kolesnikova L. I., Bairova T. A., Pervushina O. A. and Grebenkina L. A. 2015 Association of (192) Q>R polymorphism of the paraoxonase gene with a lipid profile and components of lipid peroxidation and antioxidant protection in populations of Russians and Buryats from eastern Siberia. Genetika 51, 236–241.

    CAS  PubMed  Google Scholar 

  • Košir R., Španinger K. and Rozman D. 2013 Circadian events in human diseases and in cytochrome p450-related drug metabolism and therapy. IUBMB Life 65, 487–496.

    Article  PubMed  CAS  Google Scholar 

  • Koutros S., Berndt S. I., Barry K. H., Andreotti G., Hoppin J. A. and Sandler D. P. 2013 Genetic susceptibility loci, pesticide exposure and prostate cancer risk. PLoS One 8, e58195.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Küçükali C. I., Ulusoy C., Özkan Ö., Orhan N., Güleç H., Erdağ E. et al. 2015 Evaluation of paraoxonase 1 polymorphisms in patients with bipolar disorder. In Vivo 29, 103–108.

    PubMed  Google Scholar 

  • Kudchodkar B. J., Lacko A. G., Dory L. and Fungwe T. V. 2000 Dietary fat modulates serum paraoxonase 1 activity in rats . J. Nutr. 130, 2427–2433.

    CAS  PubMed  Google Scholar 

  • Lang T., Klein K., Fischer J., Nüssler A. K., Neuhaus P., Hofmann U. et al. 2001 Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenet. Genomics 11, 399–415.

    Article  CAS  Google Scholar 

  • Lee J. Y., Vinayagamoorthy N., Han K., Kwok S. K., Ju J. H. et al. 2016 Association of polymorphisms of cytochrome P450 2D6 with blood hydroxychloroquine levels in patients with systemic lupus erythematosus. Arthritis Rheum. 68, 184–190.

    Article  CAS  Google Scholar 

  • Leon D. J., Susce M. T., Pan R. -M., Koch W. H. and Wedlund P. J. 2005 Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J. Clin. Psychopharm. 25, 448–456.

    Article  Google Scholar 

  • Leoni C., Buratti F. M. and Testai E. 2008 The participation of human hepatic p450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol. 233, 343–352.

    Article  CAS  PubMed  Google Scholar 

  • Li W. F., Costa L. G., Richter R. J., Hagen T., Shih D. M., Tward A. et al. 2000 Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 10, 1–13.

    Article  Google Scholar 

  • Liu C., Bednarska A. J., Sibly R. M., Murfitt R. C., Edwards P. and Thorbek P. 2013 Incorporating toxicokinetics into an individual-based model for more realistic pesticide exposure estimates: a case study of the wood mouse. Ecol. Model. 280, 30–39.

    Article  CAS  Google Scholar 

  • Liu Y. J., Huang P. L., Chang Y. F., Chen Y. H., Chiou Y. H., Xu Z. L. and Wong R. H. 2006 GSTP1 genetic polymorphism is associated with a higher risk of DNA damage in pesticide-exposed fruit growers. Cancer Epidemiol. Biomarkers Prevent. 15, 659–666.

    Article  CAS  Google Scholar 

  • Lurie G., Wilkens L. R., Thompson P. J., McDuffie K. E., Carney M. E., Terada K. Y. and Goodman M. T. 2008 Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol. Biomarkers Prevent 17, 2070–2077.

    Article  CAS  Google Scholar 

  • Mackness M. I., Arrol S. and Durrington P. N. 1991 Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286, 152–154.

    Article  CAS  PubMed  Google Scholar 

  • Mansour S. A. 2004 Pesticide exposure—Egyptian scene. Toxicology 198, 91–115.

    Article  CAS  PubMed  Google Scholar 

  • Marchesani M., Hakkarainen A., Tucmainen T. P., Kaikkonen J., Pukkala E., Uimari P. et al. 2003 New paraoxonase 1 polymorphism S102V and the risk of protate cancer in Finnish men. J. Natl. Cancer Inst. 95, 812–818.

    Article  CAS  PubMed  Google Scholar 

  • Mazur A. 1946 An enzyme in animal tissues capable of hydrolyzing the phosphorus-flourene bond of alkyl fluorophosphates. J. Biol. Chem. 164, 271–289.

    CAS  PubMed  Google Scholar 

  • Mercey G., Verdelet T., Renou J., Kliachyna M., Baati R., Nachon F. et al. 2012 Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc. Chem. Res. 45, 756–766.

    Article  CAS  PubMed  Google Scholar 

  • Meunier B., De Visser S. P. and Shaik S. 2004 Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chem. Rev. 104, 3947–3980.

    Article  CAS  PubMed  Google Scholar 

  • Michael M. D., Kilgore M. W., Morohashi K. and Simpson E. R. 1995 Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem. 270, 13561–13566.

    Article  CAS  PubMed  Google Scholar 

  • Mileson B. E., Chambers J. E., Chen W. L., Dettbarn W., Ehrich M., Eldefrawi A. T. et al. 1998 Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol. Sci. 41, 8–20.

    CAS  PubMed  Google Scholar 

  • Mochizuki H., Scherer S. W., Xi T., Nickle D. C., Majer M., Huizenga J. J. et al. 1998 Human pon2 gene at 7q21.3: Cloning., multiple mrna forms, and missense polymorphisms in the coding sequence. Gene 213, 149–157.

    Article  CAS  PubMed  Google Scholar 

  • Mohapatra P. and Pattanaik S. 2013 Origin, evolution and diversity of phosphotriesterases—an organophosphate degrading enzyme. An International Quarterly. J. Exp. Biol. 3, 123–132.

    Google Scholar 

  • Mostafalou S. and Abdollahi M. 2012 Concerns of environmental persistence of pesticides and human chronic diseases. Clin. Exp. Pharmacol. Physiol. S5, e002.

    Google Scholar 

  • Muñoz-Quezada M. T., Lucero B. A., Barr D. B., Steenland K., Levy K., Ryan P. B. et al. 2013 Neurodevelopmental effects in children associated with exposure to organophosphate pesticides: a systematic review. Neurotoxicology 39, 158–168.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Murata M., Watanabe M., Yamanaka M., Kubota Y., Ito H. et al. 2001 Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 165, 171–177.

    Article  CAS  PubMed  Google Scholar 

  • Murray M. I. C. H. A. E. L. 1999 Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review). Int. J. Mol. Med. 3, 227–265.

    CAS  PubMed  Google Scholar 

  • Nassar A. F. (ed.) 2010 Biotransformation and metabolite elucidation of xenobiotics: characterization and identification, pp. 200–290. John Wiley, New York, USA.

  • Ng C. J., Wadleigh D. J., Gangopadhyay A., Hama S., Grijalva V. R., Navab M. et al. 2001 Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276, 44444–44449.

    Article  CAS  PubMed  Google Scholar 

  • Nishio E. and Watanabe Y. 1997 Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem. Biophys. Res. Commun. 236, 289–293.

    Article  CAS  PubMed  Google Scholar 

  • Obare S. O., De C., Guo W., Haywood T. L., Samuels T. A., Adams C. P. et al. 2010 Fluorescent chemosensors for toxic organophosphorus pesticides: a review. Sensors 10, 7018–7043.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Otocka-Kmiecik A. and Orłowska-Majdak M 2013 The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase. Postepy. Hig. Med. Dosw. 63, 668–677.

    Google Scholar 

  • Paine M. F., Hart H. L., Ludington S. S., Haining R. L., Rettie A. E. and Zeldin D. C. 2006 The human intestinal cytochrome P450 “PIE”. Drug Metab. Dispos. 34, 880–886.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parrón T., Requena M., Hernández A. F. and Alarcón R. 2011 Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol. Appl. Pharmacol. 256, 379–385.

    Article  PubMed  CAS  Google Scholar 

  • Parul G., Kapil G., Surjit S., Ashish B., Navneet S., Gill K. D. et al. 2012 Role of paraoxonases in detoxification of organophosphates. JARBS 4, 320–325.

    Google Scholar 

  • Pei L., Petrikovics I. and Way J. 1995 Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase. Toxicol. Sci. 28, 209–214.

    Article  CAS  Google Scholar 

  • Petry C. J., Ong K. K., Michelmore K. F., Artigas S., Wingate D. L. et al. 2005 Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum. Reprod. 20, 1837–1843.

    Article  CAS  PubMed  Google Scholar 

  • Poet T. S., Wu H., Kousba A. A. and Timchalk C. 2003 In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. Toxicol. Sci. 72, 193–200.

    Article  CAS  PubMed  Google Scholar 

  • Pope C., Karanth S. and Liu J. 2005 Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ. Toxicol. Pharmacol. 19, 433–446.

    Article  CAS  PubMed  Google Scholar 

  • Primo-Parmo S. L., Sorenson R. C., Teiber J. and Du B. N. L. 1996 The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498–507.

    Article  CAS  PubMed  Google Scholar 

  • Ragnarsdottir K. V. 2000 Environmental fate and toxicology of organophosphate pesticides. J. Geol. Soc. 157, 859–876.

    Article  CAS  Google Scholar 

  • Reffstrup T. K., Larsen J. C. and Meyer O. 2010 Risk assessment of mixtures of pesticides. Current approaches and future strategies. Regul. Toxicol. Pharmacol. 56, 174–192.

    Article  CAS  PubMed  Google Scholar 

  • Richard S. A., Frank E. A. and D’Souza C. J 2013 Correlation between cholinesterase and paraoxonase 1 activities: case series of pesticide poisoning subjects. BioImpacts 3, 119–122.

    PubMed  PubMed Central  Google Scholar 

  • Rodrigo L., Hernández A. F., Lopez-Caballero J. J., Gil F. and Pla A. 2001 Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem. Biol. Interact. 137, 123–137.

    Article  CAS  PubMed  Google Scholar 

  • Roman L. J., Palmer C. N. A., Clark J. E., Muerhoff A. S., Griffin K. J., Johnson E. F. et al. 1993 Expression of rabbit cytochromes P4504A which catalyze the ω-hydroxylation of arachidonic acid, fatty acids, and prostaglandins. Arch. Biochem. Biophys. 307, 57–65.

    Article  CAS  PubMed  Google Scholar 

  • Rose R., Tang J., Choi J., Cao Y., Usmani A., Cherrington N. et al. 2005 Pesticide metabolism in humans, including polymorphisms. Scand. J. Work Environ. Health 31, 156–163.

    CAS  PubMed  Google Scholar 

  • Rosenblat M., Elias A., Volkova N. and Aviram M. 2013 Monocyte-macrophage membrane possesses free radicals scavenging activity: stimulation by polyphenols or by paraoxonase 1 (PON1). Free Radic. Res. 47, 257–267.

    Article  CAS  PubMed  Google Scholar 

  • Ross S. M., McManus I., Harrison V. and Mason O. 2013 Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review. Crit. Rev. Toxicol. 43, 21–44.

    Article  CAS  PubMed  Google Scholar 

  • Rydberg P. 2012 Theoretical study of the cytochrome p450 mediated metabolism of phosphorodithioate pesticides. J. Chem. Theory Comput. 8, 2706–2712.

    Article  CAS  PubMed  Google Scholar 

  • Saadi H. S. and Abdollahi M. 2012 The importance of pesticides effects on human reproduction in farmers. Int. J. Pharm. 8, 467–469.

    Article  Google Scholar 

  • Samer C. F., Lorenzini K. I., Rollason V., Daali Y. and Desmeules J. A. 2013 Applications of CYP450 testing in the clinical setting. Mol. Diagn. Ther. 17, 165–184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sams C., Mason H. J. and Rawbone R. 2000 Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Toxicol. Lett. 116, 217–221.

    Article  CAS  PubMed  Google Scholar 

  • Sanghera D. K., Aston C. E., Saha N. and Kamboh M. I. 1998 DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am. J. Hum. Genet. 62, 36–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schmucker D. L., Woodhouse K. W., Wang R. K., Wynne H., James O. F. and Kremers P. 1990 Effects of age and gender on in vitro properties of human liver. Clin. Pharmacol. Ther. 48, 365–374.

    Article  CAS  PubMed  Google Scholar 

  • Sevior D. K., Pelkonen O. and Ahokas J. T. 2012 Hepatocytes: the powerhouse of biotransformation. Int. J. Biochem. Cell Biol. 44, 257–261.

    Article  CAS  PubMed  Google Scholar 

  • Shenhar-Tsarfaty S., Waiskopf N., Ofek K., Shopin L., Usher S., Berliner S. et al. 2013 Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities. Eur. J. Neurol. 20, 891–898.

    Article  CAS  PubMed  Google Scholar 

  • Shi X., Dick R. A., Ford K. A. and Casida J. E. 2009 Enzymes and inhibitors in neonicotinoid insecticide metabolism. J. Agricult. Food Chem. 57, 4861–4866.

    Article  CAS  Google Scholar 

  • Shih D. M., Gu L., Hama S., Xia Y. R., Navab M., Fogelman A. M. et al. 1996 Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J. Clin. Invest. 97, 1630–1639.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singh A. K., Tiwari M. N., Upadhyay G., Patel D. K., Singh D., Prakash O. et al. 2012 Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol. Aging 33, 404–415.

    Article  CAS  PubMed  Google Scholar 

  • Singh S., Kumar V., Singh P., Thakur S., Banerjee B. D., Rautela R. S. et al. 2011 Genetic polymorphisms of GSTM1, GSTT1 and GSTP1 and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Mutat. Res. Genet. Tox. 725, 36–42.

    Article  CAS  Google Scholar 

  • Smutny T., Mani S. and Pavek P. 2013 Post-translational and post-transcriptional modifications of pregnane X receptor PXR in regulation of the cytochrome P450 superfamily. Curr. Drug. Metab. 14, 1059–1069.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sotaniemi E. A., Arranto A. J., Pelkonen O. and Pasanen M. 1997 Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin. Pharmacol. Ther. 61, 331–339.

    Article  CAS  PubMed  Google Scholar 

  • Sözmen B., Peker S., Kaya Ü., Erkan M. and Sözmen E. Y. 2007 Markers of long-term exposure to organophosphorus pesticides in farmers who work in viniculture and tobacco production in turkey. Toxicol. Mech. Meth. 17, 379–384.

    Article  CAS  Google Scholar 

  • Tang J., Cao Y., Rose R. L., Brimfield A. A., Dai D., Goldstein J. A. et al. 2001 Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Dispos. 29, 1201–1204.

    CAS  PubMed  Google Scholar 

  • Tang J., Cao Y., Rose R. L. and Hodgson E. 2002 In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem. Biol. Interact. 141, 229–241.

    Article  CAS  PubMed  Google Scholar 

  • Tavilani H., Fattahi A., Esfahani M., Khodadadi I., Karimi J., Bahrayni E. et al. 2014 Genotype and phenotype frequencies of paraoxonase 1 in fertile and infertile men. Syst. Biol. Reprod. Med. 60, 361–366.

    Article  CAS  PubMed  Google Scholar 

  • Timbrell J. A. and Marrs T. C. 2009 Biotransformation of xenobiotics. General, Applied and Systems Toxicology. John Wiley, New York, USA.

  • Toptaş B., Kurt Ö., Aydoğan H. Y., Yaylim I., Zeybek Ü., Can A. et al. 2013 Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients. Mol. Biol. Rep. 40, 6519–6524.

    Article  PubMed  CAS  Google Scholar 

  • Tsatsakis A., Zafiropoulos A., Tzatzarakis M., Tzanakakis G. and Kafatos A. 2009 Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a greek rural population professionally exposed to pesticides. Toxicol. Lett. 186, 66–72.

    Article  CAS  PubMed  Google Scholar 

  • Uematsu F., Ikawa S., Kikuchi H., Sagami I., Kanamaru R. et al. 1994 Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenet. Genomics 4, 58–63.

    Article  CAS  Google Scholar 

  • Usmani K. A., Cho T. M., Rose R. L. and Hodgson E. 2006 Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals. Drug Metab. Dispos. 34, 1606–1614.

    Article  CAS  PubMed  Google Scholar 

  • Vecchini F., Mace K., Magdalou J., Mahe Y., Bernard B. A. and Shroot B. 1995 Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes. Br. J. Dermatol. 132, 14–21.

    Article  CAS  PubMed  Google Scholar 

  • Victoria L. S., Carmen R., Alexandre L. P., Michael J. T. and Eugenia E. C. 2006 Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II nutrition cohort. Cancer Epidemiol. Biomarkers Prev. 15, 1226–1228.

    Article  Google Scholar 

  • Wallace A. J., Sutherland W. H. F., Mann J. I. and Williams S. M. 2001 The effect of meals rich in thermally stressed olive oil and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur. J. Clin. Nutr. 55, 951–958.

    Article  CAS  PubMed  Google Scholar 

  • Wang X., Fan Z., Huang J., Su S., Yu Q., Zhao J. et al. 2003 Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 23, 328–334.

    Article  CAS  PubMed  Google Scholar 

  • Wang Z., Zhang Y., Kong X., Li S., Hu Y., Wang R. et al. 2013 Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population. Diagn. Pathol. 8, 186.

    PubMed  PubMed Central  Google Scholar 

  • Wanner R., Brommer S., Czarnetzki B. M. and Rosenbach T. 1995 The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem. Biophys. Res. Commun. 209, 706–711.

    Article  CAS  PubMed  Google Scholar 

  • Warrington J. S., Greenblatt D. J. and von Moltke L. L. 2004 Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. J. Pharmacol. Exp. Ther. 309, 720–729.

    Article  CAS  PubMed  Google Scholar 

  • Wauthier V., Verbeeck R. K. and Calderon P. B. 2004 Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress? Arch. Toxicol. 78, 131–138.

    Article  CAS  PubMed  Google Scholar 

  • Wilkinson G. R. 2005 Drug metabolism and variability among patients in drug response. N. Engl. J. Med. 352, 2211–2221.

    Article  CAS  PubMed  Google Scholar 

  • Yang Y. N., Wang X. L., Ma Y. T., Xie X., Fu Z. Y. et al. 2010 Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population. Clin. Appl. Thromb. Hemost. 16, 579–583.

    Article  CAS  PubMed  Google Scholar 

  • You T., Lv J. and Zhou L. 2013 Pon1 q192R and L55M polymorphisms and organophosphate toxicity risk: a meta-analysis. DNA Cell Biol. 32, 252–259.

    Article  CAS  PubMed  Google Scholar 

  • Zanger U. M., Turpeinen M., Klein K. and Schwab M. 2008 Functional pharmacogenetics/genomics of human cytochromes p450 involved in drug biotransformation. Anal. Bioanal. Chem. 392, 1093–1108.

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y., Liu H., He J., Xu K., Bai H., Wang Y. et al. 2015 Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome. Eur. J. Endocrinol. 172, 391–402.

    Article  CAS  PubMed  Google Scholar 

  • Zhuang X. M., Wei X., Tan Y., Xiao W. B., Yang H. Y., Xie J. W. et al. 2014 Contribution of carboxylesterase and cytochrome P450 to the bioactivation and detoxification of isocarbophos and its enantiomers in human liver microsomes. Toxicol. Sci. 140, 40–48.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Vice-Chancellor of CUPB for the support. The work was supported by CUPB-RSM and UGC start-up grants. GK is also thankful to UGC for Moalana Azad National Fellowship. We also thank Dr Alpna Saini, Centre for Classical and Modern Languages, Central University of Punjab, for editing and improving the language.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to SANDEEP SINGH.

Additional information

Corresponding editor: Kunal Ray

[Kaur G., Jain A. K. and Singh S. 2017 CYP/PON genetic variations as determinant of organophosphate pesticides toxicity. J. Genet. 96, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

KAUR, G., JAIN, A.K. & SINGH, S. CYP/PON genetic variations as determinant of organophosphate pesticides toxicity. J Genet 96, 187–201 (2017). https://doi.org/10.1007/s12041-017-0741-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-017-0741-7

Keywords

Navigation